Arbutus Biopharma Corporation

Quick facts

Phase 2 pipeline

• ARB-001467 · Infectious Diseases
  ARB-001467 is an investigational drug that targets the hepatitis B virus.

Phase 1 pipeline

• TKM-080301

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Arbutus Biopharma Corporation portfolio CI brief
• Arbutus Biopharma Corporation pipeline updates RSS